Novoray(SH:688300)2020-10-21 16:00Financial Performance - Operating revenue for the first nine months was ¥278,636,439.92, representing a year-on-year growth of 22.87%[11] - Net profit attributable to shareholders was ¥70,882,590.33, up 32.71% from the same period last year[11] - The company reported a net profit of ¥63,217,014.43 after deducting non-recurring gains and losses, which is a 24.62% increase year-on-year[11] - Operating profit for the third quarter of 2020 was ¥32,447,484.13, compared to ¥21,196,225.17 in the third quarter of 2019, reflecting a growth of 53.2%[48] - Net profit for the third quarter of 2020 was ¥28,116,235.83, up 54.3% from ¥18,219,030.64 in the same quarter of 2019[51] - The total profit for the first three quarters of 2020 was ¥81,753,155, up 31.5% from ¥62,127,037 in the same period of 2019[61] Cash Flow - The net cash flow from operating activities for the first nine months was ¥76,632,463.70, an increase of 29.23% year-on-year[11] - Cash flow from operating activities for the first three quarters of 2020 was ¥76,632,464, an increase from ¥59,297,202 in the same period of 2019[63] - The company reported a total cash inflow from operating activities of ¥274,170,953 in the first three quarters of 2020, compared to ¥198,367,628 in the same period of 2019[63] - The company recorded a significant cash recovery from investments of ¥963,800,000 in Q3 2020[63] - The cash flow from financing activities showed a net outflow of -CNY 71,691,834.89, compared to -CNY 23,612,202.22 in the previous year, reflecting a worsening cash position[68] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,044,047,686.71, an increase of 1.99% compared to the end of the previous year[11] - Total liabilities decreased to ¥120,222,423.23 from ¥127,577,557.30, a reduction of about 5.6%[42] - Current assets totaled ¥778,408,854.55, down from ¥826,257,301.52, indicating a decline of approximately 5.8%[39] - The company's total equity reached ¥923,826,787.33, an increase from ¥896,148,961.89 in the previous period[44] - The total liabilities and equity amounted to ¥1,044,047,686.71, up from ¥1,023,726,519.19, indicating a growth of about 2.0%[39] Research and Development - Research and development expenses accounted for 5.53% of operating revenue, an increase of 1.44 percentage points compared to the previous year[13] - Research and development expenses rose by 66.10% to ¥15,407,340.55 from ¥9,275,816.58, reflecting increased investment in R&D[24] - Research and development expenses for the first three quarters of 2020 totaled ¥15,407,340.55, an increase of 66.5% compared to ¥9,275,816.58 in the same period of 2019[48] Shareholder Information - The total number of shareholders at the end of the reporting period was 4,665[14] - The company’s basic and diluted earnings per share were both ¥0.82[13] Government Subsidies - The company received government subsidies amounting to ¥2,157,191.68 for the first nine months, which are closely related to its normal business operations[13] Inventory and Receivables - Accounts receivable decreased by 52.39% to ¥3,071,892.44 from ¥6,451,936.40 primarily due to a reduction in commercial notes received[23] - Inventory levels increased to ¥48,741,201.96 from ¥45,562,407.99, showing a growth of approximately 4.8%[39] Other Financial Metrics - The weighted average return on equity decreased by 8.13 percentage points to 7.77% compared to the previous year[11] - Investment income increased significantly by 1640.12% to ¥7,310,660.32 from ¥420,124.66, driven by higher interest income from structured deposits[24] - The company reported a total comprehensive income of ¥27,927,322.40 for the third quarter of 2020, compared to ¥18,219,030.64 in the same quarter of 2019[53] Future Plans - The company plans to continue investing in new product development and market expansion strategies to drive future growth[49]